Literature DB >> 6707948

Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney.

A S Bass, N W Robie.   

Abstract

The stereoselectivity of S (S)- and R (R)-sulpiride for the pre-(prereceptor) and post (postreceptor) synaptic dopamine receptors has been examined in various tissues. In the present study, the effects of S and R on the pre- and postreceptor in the canine kidney were investigated. The left renal artery of pentobarbital-anesthetized dogs was exposed and mean arterial pressure and renal blood flow were monitored. Vasoconstrictor stimuli [nerve stimulation: 1-8 Hz, 2 msec, 10-20 V, 5 sec; norepinephrine: 0.25-1.0 micrograms i.a.] were produced before and during graded doses of dopamine (DA: 0.3-2.4 micrograms/kg/min i.a.) administration. After a 15-minute recovery period, vasoconstrictor stimuli were repeated before and during the reinfusion of DA at the 2.4-micrograms/kg/min dose. While continuing DA, S or R (0.06-15.6 micrograms/kg/min) was administered and vasoconstrictor stimuli were repeated. DA antagonized the response to nerve stimulation but not norepinephrine (P less than .05). This effect of DA was antagonized by S at a dose of 0.12 micrograms/kg/min but not R. S and R alone did not affect the response to nerve stimulation. In dogs pretreated with phenoxybenzamine (5 mg/kg i.a.), DA produced a decrease in renal vascular resistance (P less than .05) and a dose of 15.6 micrograms/kg/min of either S or R was required to block this effect of DA. Therefore, S is 130 times more stereoselective for the prereceptor, whereas S and R are equipotent at the postreceptor in the canine kidney.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707948

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Dissociation of renal vasodilator and natriuretic effects of dopamine during sulpiride infusion in normal man.

Authors:  A J Smit; S Meijer; H Wesseling; A J Donker; W D Reitsma
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

Authors:  L C Rump; K Wilde; C Bohmann; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

4.  Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices.

Authors:  L C Rump; E Schwertfeger; U Schaible; M J Schuster; A Frankenschmidt; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Octopamine relaxes rabbit jejunal smooth muscle by selective activation of dopamine D1 receptors.

Authors:  J T Cheng; S C Hsieh-Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

6.  The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride.

Authors:  S Freestone; T M MacDonald; R F Jeffrey; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

7.  (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.

Authors:  T M MacDonald; R F Jeffrey; S Freestone; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.